Literature DB >> 28278128

Cancer metastasis - tricks of the trade.

Rabia Zeeshan1, Zeeshan Mutahir.   

Abstract

Decades of cancer research have unraveled genetic, epigenetic and molecular pathways leading to plausible therapeutic targets; many of which hold great promise in improving clinical outcomes. Metastatic tumors become evident early on and are one of the major causes of cancer-related fatalities worldwide. This review depicts the sequential events of cancer metastasis. Genetic and epigenetic heterogeneity influences local tumor cell invasion, intravasation, survival in circulation, extravasation and colonization to distant sites. Each sequential event is associated with heterogeneous tumor microenvironment, gain of competence, unique population of cancer stem cells (CSCs), circulatory pathway, compatible niche and immune system support. A tight regulation of metastasis-promoting mechanisms and, in parallel, evading inhibitory mechanisms contribute to the severity and site of metastasis. A comprehensive understanding of tumor cell fate as an individual entity, as well as in combination with different promoting factors and associated molecular mechanisms, is anticipated in the coming years. This will enable scientists to depict design strategies for targeted cancer therapies.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28278128      PMCID: PMC5581965          DOI: 10.17305/bjbms.2017.1908

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  138 in total

1.  Potentiation of neuroblastoma metastasis by loss of caspase-8.

Authors:  Dwayne G Stupack; Tal Teitz; Matthew D Potter; David Mikolon; Peter J Houghton; Vincent J Kidd; Jill M Lahti; David A Cheresh
Journal:  Nature       Date:  2006-01-05       Impact factor: 49.962

Review 2.  Microenvironmental regulation of tumor progression and metastasis.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

Review 3.  Regulatory networks defining EMT during cancer initiation and progression.

Authors:  Bram De Craene; Geert Berx
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

4.  VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors.

Authors:  Xin Lu; Euphemia Mu; Yong Wei; Sabine Riethdorf; Qifeng Yang; Min Yuan; Jun Yan; Yuling Hua; Benjamin J Tiede; Xuemin Lu; Bruce G Haffty; Klaus Pantel; Joan Massagué; Yibin Kang
Journal:  Cancer Cell       Date:  2011-12-01       Impact factor: 31.743

5.  Ectopic expression of vascular cell adhesion molecule-1 as a new mechanism for tumor immune evasion.

Authors:  Ken-Yu Lin; Dan Lu; Chien-Fu Hung; Shiwen Peng; Lanqing Huang; Chunfa Jie; Francisco Murillo; Jesse Rowley; Ya-Chea Tsai; Liangmei He; Dae-Jin Kim; Elizabeth Jaffee; Drew Pardoll; T-C Wu
Journal:  Cancer Res       Date:  2007-02-15       Impact factor: 12.701

6.  Multiplexed ion beam imaging of human breast tumors.

Authors:  Michael Angelo; Sean C Bendall; Rachel Finck; Matthew B Hale; Chuck Hitzman; Alexander D Borowsky; Richard M Levenson; John B Lowe; Scot D Liu; Shuchun Zhao; Yasodha Natkunam; Garry P Nolan
Journal:  Nat Med       Date:  2014-03-02       Impact factor: 53.440

Review 7.  The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis.

Authors:  Sandra S McAllister; Robert A Weinberg
Journal:  Nat Cell Biol       Date:  2014-08       Impact factor: 28.824

8.  Wnt inhibitory factor-1, a Wnt antagonist, is silenced by promoter hypermethylation in malignant pleural mesothelioma.

Authors:  Sonny Batra; Yihui Shi; Kristopher M Kuchenbecker; Biao He; Noemi Reguart; Iwao Mikami; Liang You; Zhidong Xu; Yu-Ching Lin; Geneviève Clément; David M Jablons
Journal:  Biochem Biophys Res Commun       Date:  2006-02-24       Impact factor: 3.575

9.  Natural history of early, localized prostate cancer.

Authors:  Jan-Erik Johansson; Ove Andrén; Swen-Olof Andersson; Paul W Dickman; Lars Holmberg; Anders Magnuson; Hans-Olov Adami
Journal:  JAMA       Date:  2004-06-09       Impact factor: 56.272

10.  Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas.

Authors:  Arnout G Schepers; Hugo J Snippert; Daniel E Stange; Maaike van den Born; Johan H van Es; Marc van de Wetering; Hans Clevers
Journal:  Science       Date:  2012-08-01       Impact factor: 47.728

View more
  39 in total

1.  StarD13 differentially regulates migration and invasion in prostate cancer cells.

Authors:  Leila Jaafar; Isabelle Fakhoury; Sahar Saab; Layal El-Hajjar; Wassim Abou-Kheir; Mirvat El-Sibai
Journal:  Hum Cell       Date:  2021-01-09       Impact factor: 4.174

Review 2.  Molecular Mechanism of β-Sitosterol and its Derivatives in Tumor Progression.

Authors:  Xingxun Bao; Yanan Zhang; Hairong Zhang; Lei Xia
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

Review 3.  Synergies of Extracellular Vesicles and Microchimerism in Promoting Immunotolerance During Pregnancy.

Authors:  José M Murrieta-Coxca; Paulina Fuentes-Zacarias; Stephanie Ospina-Prieto; Udo R Markert; Diana M Morales-Prieto
Journal:  Front Immunol       Date:  2022-07-01       Impact factor: 8.786

Review 4.  Peptide-Modified Biopolymers for Biomedical Applications.

Authors:  Jessica Hersh; David Broyles; José Manuel Condor Capcha; Emre Dikici; Lina A Shehadeh; Sylvia Daunert; Sapna Deo
Journal:  ACS Appl Bio Mater       Date:  2020-12-24

5.  ANLN promotes carcinogenesis in oral cancer by regulating the PI3K/mTOR signaling pathway.

Authors:  Bing Wang; Xiao-Li Zhang; Chen-Xi Li; Ning-Ning Liu; Min Hu; Zhong-Cheng Gong
Journal:  Head Face Med       Date:  2021-06-03       Impact factor: 2.151

Review 6.  Extracellular Matrix: Emerging Roles and Potential Therapeutic Targets for Breast Cancer.

Authors:  Yunchun Zhao; Xiaoling Zheng; Yongquan Zheng; Yue Chen; Weidong Fei; Fengmei Wang; Caihong Zheng
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

7.  Lidocaine represses the malignant behavior of lung carcinoma cells via the circ_PDZD8/miR-516b-5p/GOLT1A axis.

Authors:  Huafen Zi; Li Chen; Qian Ruan
Journal:  Histol Histopathol       Date:  2022-01-21       Impact factor: 2.303

Review 8.  Nanotechnology-based immunotherapies to combat cancer metastasis.

Authors:  Yuping Zhao; Muhammad Bilal; Maimoona Qindeel; Muhammad Imran Khan; Kuldeep Dhama; Hafiz M N Iqbal
Journal:  Mol Biol Rep       Date:  2021-08-23       Impact factor: 2.316

9.  Activating Sphingosine-1-phospahte signaling in endothelial cells increases myosin light chain phosphorylation to decrease endothelial permeability thereby inhibiting cancer metastasis.

Authors:  Yu-Chi Chen; Saketh S Dinavahi; Qilong Feng; Raghavendra Gowda; Srinivasa Ramisetti; Xinghai Xia; Kyle B LaPenna; Venkat R Chirasani; Sung Hyun Cho; Susan L Hafenstein; Madhu Babu Battu; Arthur Berg; Arun K Sharma; Tom Kirchhausen; Nikolay V Dokholyan; Shantu Amin; Pingnian He; Gavin P Robertson
Journal:  Cancer Lett       Date:  2021-02-16       Impact factor: 9.756

Review 10.  Molecular and Metabolic Reprogramming: Pulling the Strings Toward Tumor Metastasis.

Authors:  Ana Hipólito; Filipa Martins; Cindy Mendes; Filipa Lopes-Coelho; Jacinta Serpa
Journal:  Front Oncol       Date:  2021-06-03       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.